JAK2/FLT3-IN-1 T11707
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
JAK2/FLT3-IN-1 has anti-cancer activity. JAK2/FLT3-IN-1 is a potent and orally effective dual JAK2/FLT3 (Janus kinase 2/ FMS-like tyrosine kinase 3) inhibitor with IC50 values of 0.7 nM, 4 nM, 26 nM and 39 nM for JAK2, FLT3, JAK1 and JAK3, respectively.
CAS nr:
2387765-27-5
Purity:
98%
Molecular Weight:
467,58
SMILES:
OCCN(C1CCN(C2=CC=C(NC3=NC=C(C)C(C4=CN(C(C)C)N=C4)=N3)C=C2F)CC1)C
Formula:
C25H34FN7O
Pathway:
MAPK
Target:
JNK

"Croyez" specializes in bringing scientists "absolute solution" products for all applications of the protein research area. They offer recombinant protein GMP and RUO grade, mRNA synthesis raw material, Molecular Diagnosis raw material, Allergen raw material, COVID -19 antibody and antigen and Later flow products. Every tool you need to fulfill your research experiment in the protein area, Croyez has relevant products to offer. They also provide CRO/CDMO service, customize protein production, customize monoclonal antibody production, customize immunoassay platform and Diagnosis platform development.